249 related articles for article (PubMed ID: 10390602)
1. Mizoribine and mycophenolate mofetil.
Ishikawa H
Curr Med Chem; 1999 Jul; 6(7):575-97. PubMed ID: 10390602
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis.
González-Rivera TC; McCune J
Immunotherapy; 2011 Dec; 3(12):1431-40. PubMed ID: 22091679
[TBL] [Abstract][Full Text] [Related]
3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
4. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil--clinical and experimental experience.
Pirsch JD; Sollinger HW
Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
Yashima Y; Ohgane T
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.
Xing S; Yang J; Zhang X; Zhou P
Clin Biochem; 2014 May; 47(7-8):663-9. PubMed ID: 24463228
[TBL] [Abstract][Full Text] [Related]
9. Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.
Shimmura H; Tanabe K; Habiro K; Abe R; Toma H
Transplantation; 2006 Jul; 82(2):175-9. PubMed ID: 16858279
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus
Zhang Q; Yang B; Li F; Liu M; Lin S; Wang J; Xue Y; Zhu H; Sun W; Hu Z; Zhang Y
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 29986508
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.
Takahara S; Takahashi K; Akiyama T; Uchida K; Tanabe K; Amada N; Toma H
Clin Exp Nephrol; 2013 Dec; 17(6):899-904. PubMed ID: 23430390
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil: An update.
Villarroel MC; Hidalgo M; Jimeno A
Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
[TBL] [Abstract][Full Text] [Related]
14. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid, mycophenolate mofetil, mizoribine, ribavirin, and 7-nitroindole inhibit propagation of Babesia parasites by targeting inosine 5'-monophosphate dehydrogenase.
Cao S; Aboge GO; Terkawi MA; Zhou M; Kamyingkird K; Moumouni PF; Masatani T; Igarashi I; Nishikawa Y; Suzuki H; Xuan X
J Parasitol; 2014 Aug; 100(4):522-6. PubMed ID: 24580148
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of mycophenolate mofetil: recent data and clinical consequences].
Thervet E; Anglicheau D; Legendre C
Nephrologie; 2001; 22(7):331-7. PubMed ID: 11817210
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients.
Sugiyama K; Satoh H; Saito K; Takahashi K; Saito N; Hirano T
Transpl Int; 2005 May; 18(5):590-5. PubMed ID: 15819809
[TBL] [Abstract][Full Text] [Related]
19. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M
Nephrol Dial Transplant; 1999 Jan; 14(1):58-63. PubMed ID: 10052478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
